Laura E. Niklason, President, CEO and Director at Humacyte, Inc. (HUMA), sold 4,875,000 shares at $2.60 ($12.7M) on 2023-06-13, disclosed to the SEC on 2023-06-15.
Open-market sale of $12.7M HUMA by President, CEO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |